ebolavirus
compris
speci
exert
vari
degre
mortalityinfect
human
show
highest
howev
molecular
basi
differenti
mortalityinfect
remain
unclear
report
structur
featur
ebolaviru
envelop
glycoprotein
gp
one
counter
receptor
macrophag
galactosetyp
calciumtyp
lectin
play
crucial
role
determin
viral
infect
low
infect
rebov
mediat
interact
gp
dramat
increas
ntermin
amino
acid
gp
replac
zebov
furthermor
structur
analysi
glycan
gp
reveal
nglycan
extend
rebov
zebov
nglycan
extens
revers
replac
aforement
ntermin
amino
acid
residu
therefor
data
strongli
suggest
extend
nglycan
gp
reduc
viral
infect
hinder
interact
gp
preferenti
bind
oglycan
involv
glycanlectin
bind
initi
virushost
interact
wide
known
yet
structur
basi
interact
fulli
understood
lectin
surfac
virus
influenza
viru
surfac
glycan
present
ebolaviru
ebov
suppos
play
signific
role
ebov
belong
famili
filovirida
caus
sever
hemorrhag
fever
human
nonhuman
primat
mechan
pathogenesi
ebov
infect
remain
mostli
unknown
make
paramount
understand
mechan
infect
develop
effect
therapi
solv
biolog
question
virul
viral
diseas
gave
rise
sinc
pathogenesi
ebov
involv
inflamm
vascular
stabil
glycanlectin
interact
take
place
surfac
macrophag
dendrit
cell
like
play
crucial
role
known
degre
pathogen
depend
viru
speci
speci
zair
ebolaviru
sudan
ebolaviru
bundibugyo
ebolaviru
tai
forest
ebolaviru
reston
ebolaviru
identifi
date
ebolavirus
belong
reston
ebolaviru
rebov
caus
symptomat
diseas
wherea
belong
publish
xx
xx
xxxx
open
wwwnaturecomscientificreport
scientif
report
zair
ebolaviru
zebov
show
highest
mortal
human
howev
molecular
basi
differenti
virul
rebov
zebov
fulli
elucid
although
appear
varieti
mechan
collect
modul
process
lead
establish
infect
pathogenesi
ebov
envelop
glycoprotein
gp
known
function
one
crucial
factor
determin
differenti
virul
gp
type
transmembran
glycoprotein
compos
mucinlik
motif
highli
modifi
nand
oglycan
transmembran
region
tether
complex
viral
surfac
cours
infect
gp
appar
involv
viral
attach
fusion
viral
envelop
host
membran
lead
subsequ
entri
cell
recent
find
gpspecif
neutral
antibodi
pseudosaccharid
could
ligand
lectin
express
host
cell
surfac
report
protect
experiment
anim
lethal
ebov
infect
also
support
notion
gp
function
crucial
element
determin
degre
infect
addit
mucinlik
domain
zebov
previous
report
essenti
infect
zebov
ctype
lectin
myeloid
cell
previous
report
act
entri
site
ebov
interact
gp
exampl
hepat
asialoglycoprotein
receptor
report
interact
nglycan
promot
viral
entri
hepatocyt
dendrit
cellspecif
intercellular
adhes
molecul
grab
nonintegrin
dcsign
dcsignrel
receptor
dcsignr
shown
bind
high
mannosetyp
nglycan
promot
entri
dendrit
cell
endotheli
lsectin
liver
lymph
node
sinusoid
endotheli
cell
ctype
lectin
recogn
nglycan
enhanc
viral
infect
previous
show
cell
becam
suscept
infect
vesicular
stomat
viru
lack
nativ
g
protein
hereaft
describ
vsv
pseudotyp
ebov
gp
macrophag
galactosetyp
calciumtyp
lectin
express
sinc
preferenti
bind
oglycan
mucinlik
domain
thought
play
import
role
interact
present
report
aim
answer
question
lethalitypathogen
rebov
lower
zebov
end
prepar
pseudotyp
virus
viruslik
particl
vlp
zebov
gp
zgp
rebov
gp
rgp
chimer
gp
use
cell
compar
gp
respect
bind
recombin
role
nglycan
oglycan
gp
bind
recombin
structur
nglycan
present
gp
exhaust
structur
analysi
demonstr
rgp
nglycan
extend
zgp
nglycan
nglycan
remov
gp
differ
bind
capac
observ
rgp
zgp
diminish
like
preferenti
bind
oglycan
gp
interf
presenc
extend
nglycan
prepar
chimer
gp
rgp
zgp
found
structur
characterist
rgp
zgp
biosynthet
determin
surprisingli
short
stretch
amino
acid
residu
irrelev
major
glycosyl
site
result
clearli
show
short
stretch
amino
acid
residu
gp
control
extens
nglycan
entir
gp
turn
degre
viral
infect
modul
interact
gp
monocytederiv
immatur
dendrit
cell
attach
ebov
host
cell
known
mediat
socal
mucinlik
domain
gp
surfac
lectin
hepatocyt
dendrit
cell
macrophag
endotheli
cell
appar
engag
viral
attach
subsequ
viral
entri
state
among
sever
ctype
lectin
express
surfac
dendrit
cell
macrophag
predomin
role
predict
base
previou
find
show
infect
vsv
pseudotyp
zgp
significantli
enhanc
cell
express
cell
report
specif
block
monoclon
antibodi
mab
significantli
reduc
infect
vsv
pseudotyp
zgp
rgp
human
monocytederiv
immatur
dc
shown
fig
pseudotyp
virus
infect
human
monocytederiv
immatur
dc
vsv
pseudotyp
rgp
less
infect
vsv
pseudotyp
zgp
preincub
immatur
dc
mab
reduc
infect
rate
compar
isotyp
control
antibodi
fig
accord
result
judg
surfac
immatur
dc
play
predomin
role
infect
cell
ebov
result
also
indic
structur
characterist
ebov
gp
determin
differenti
viral
infect
differ
vsv
pseudotyp
rgp
vsv
pseudotyp
zgp
lie
structur
gp
therefor
focus
gp
explor
molecular
basi
differenti
infect
rebov
zebov
infect
vsv
pseudotyp
gp
correl
bind
gp
vlp
infect
vsv
pseudotyp
gp
deriv
zebov
sudan
ebolaviru
sebov
rebov
examin
use
cell
pseudotyp
virus
infect
cell
effici
cell
fig
vsv
pseudotyp
zgp
sebov
gp
sgp
show
significantli
higher
infect
cell
express
vsv
pseudotyp
rgp
fig
result
strongli
suggest
structur
featur
gp
determin
degre
infect
bind
investig
correl
bind
recombin
electrophoret
separ
viral
protein
vsv
pseudotyp
zgp
zgp
lack
mucinlik
domain
sgp
rgp
compar
immunoblot
shown
fig
could
bind
zgpsgp
much
stronger
zgp
wherea
similar
differ
detect
bind
mab
recogn
common
epitop
rgp
zgp
similar
result
immunoblot
analysi
mab
use
vsv
pseudotyp
gp
bind
vlpzgp
higher
vlprgp
fig
taken
togeth
bind
intens
gp
vlp
correl
infect
pseudotyp
virus
primari
amino
acid
sequenc
socal
mucinlik
domain
zgp
respons
differenti
infect
bind
ebov
gp
mucinlik
domain
amino
acid
residu
rich
nand
oglycan
primari
amino
acid
sequenc
domain
distinct
zgp
rgp
amino
acid
sequenc
homolog
fulllength
zgp
rgp
wherea
mucinlik
domain
see
fig
amino
acid
sequenc
thu
thought
primari
amino
acid
sequenc
mucinlik
domain
determin
differenti
viral
infect
differenti
bind
test
hypothesi
gener
vsv
vlp
bear
chimer
gp
mucinlik
domain
zgp
replac
rgp
unexpectedli
infect
vsv
pseudotyp
chimer
gp
similar
vsv
pseudotyp
zgp
cell
fig
also
bind
chimer
gp
vlp
similar
zgp
vlp
fig
result
indic
primari
structur
mucinlik
domain
respons
differ
infect
differenti
bind
capac
zgp
rgp
could
test
chimer
rgp
carri
mucinlik
domain
zgp
product
pseudotyp
vsv
vlp
contain
domain
ineffici
unknown
reason
although
presenc
glycoprotein
confirm
cell
surfac
transfect
cell
consid
serthr
residu
repres
potenti
oglycosyl
site
also
present
outsid
mucinlik
domain
variou
length
polypeptid
stretch
around
mucinlik
domain
zgp
replac
correspond
region
rgp
base
aminoacid
sequenc
homolog
fig
chimer
gp
examin
viral
infect
cell
mgl
bind
capac
gp
even
amino
acid
amino
acid
includ
mucinlik
domain
amino
acid
zgp
replac
correspond
region
rgp
infect
vsv
pseudotyp
chimer
gp
similar
vsv
pseudotyp
zgp
fig
similarli
figur
posit
correl
found
infect
vsv
pseudotyp
ebov
gp
bind
gp
blockad
infect
vsv
pseudotyp
zgp
rgp
monocytederiv
dendrit
cell
monoclon
antibodi
specif
mab
calcul
number
infect
cell
vsv
pseudotyp
zgp
treat
mous
set
rel
infect
compar
ratio
valu
statist
analysi
student
ttest
perform
p
p
b
effect
express
infect
vsv
pseudotyp
zgp
sgp
rgp
experi
perform
time
repres
result
shown
calcul
number
infect
cell
vsv
pseudotyp
zgp
rgp
sgp
set
respect
rel
infect
shown
ratio
valu
statist
analysi
student
ttest
perform
bind
capac
chimer
gp
almost
ident
bind
capac
zgp
fig
howev
surpris
replac
amino
acid
residu
zgp
rgp
dramat
reduc
infect
cell
bind
capac
compar
zgp
fig
b
result
made
us
hypothes
amino
acid
residu
gp
might
regul
infect
cell
bind
capac
amino
acid
residu
zgp
rgp
critic
differenti
infect
differenti
bind
zebov
rebov
investig
role
amino
acid
residu
gp
viral
infect
bind
capac
gener
vsv
pseudotyp
chimer
zgprgp
vlp
contain
swap
amino
acid
residu
rgpzgp
fig
examin
viral
infect
cell
bind
capac
infect
vsv
pseudotyp
chimer
zgp
zgp
swap
rgp
dramat
reduc
compar
zgp
fig
similarli
bind
capac
chimer
gp
dramat
reduc
compar
zgp
fig
c
contrari
infect
vsv
pseudotyp
chimer
rgp
rgp
swap
zgp
bind
capac
mgl
chimer
rgp
dramat
increas
compar
rgp
fig
result
suggest
residu
gp
pivot
role
determin
differenti
infect
differenti
bind
zebov
rebov
investig
issu
focus
residu
among
residu
homolog
residu
rel
low
zgp
rgp
swap
residu
zgp
rgp
infect
cell
bind
capac
dramat
reduc
level
rgp
fig
c
expect
infect
vsv
pseudotyp
chimer
gp
contain
swap
residu
rgp
zgp
significantli
greater
vsv
pseudotyp
rgp
fig
similarli
bind
capac
chimer
gp
dramat
increas
compar
rgp
fig
c
result
strongli
suggest
amino
acid
residu
near
nterminu
gp
respons
biosynthesi
gp
structur
determin
interact
turn
viral
infect
cell
nglycan
oglycan
rgp
zgp
determin
interact
gp
treat
peptid
nglycanas
f
pngase
f
bind
examin
remov
nglycan
infect
vsv
pseudotyp
indic
gp
determin
use
cell
describ
materi
method
data
shown
mean
sd
triplic
experi
statist
analysi
student
ttest
perform
p
p
b
c
lysat
vlp
indic
gp
subject
immunoblot
use
upper
panel
mab
lower
panel
quantif
result
immunoblot
shown
c
n
quantif
peak
area
band
measur
rel
ratio
mab
calcul
rel
ratio
zgp
set
e
vlp
zgp
rgp
treat
untreat
pngase
f
lysat
treat
vlp
electrophoret
separ
subject
immunoblot
use
phal
mab
quantif
result
immunoblot
shown
e
n
quantif
peak
area
band
measur
rel
ratio
mab
calcul
rel
ratio
zgprgp
without
pngase
f
treatment
set
equat
use
calcul
follow
rel
ratio
mab
zgp
zgp
pngase
f
treatmentzgp
without
pngase
f
treatment
x
rel
ratio
mgl
mab
rgp
rgp
pngase
f
treatmentrgp
without
pngase
f
treatment
x
confirm
loss
phal
bind
alter
electrophoret
migrat
distanc
shown
fig
e
bind
zgp
chang
pngase
f
treatment
contrast
bind
rgp
increas
pngase
f
treatment
result
suggest
bind
mgl
gp
mediat
oglycan
nglycan
addit
bind
zgp
rgp
becam
almost
ident
pngase
f
treatment
suggest
nglycan
rgp
interf
interact
rgp
rgp
extend
nglycan
zgp
extend
nglycan
seem
inhibit
interact
gp
compar
structur
featur
nglycan
present
rgp
zgp
structur
nglycan
releas
rgp
zgp
chimer
gp
analyz
gp
immunoprecipit
dissolv
vlp
use
mab
immunoprecipit
gp
subject
ingel
pngase
f
digest
follow
glycoblot
malditof
ms
typic
ms
spectra
zgp
rgp
shown
fig
see
fig
gp
structur
featur
estim
mass
number
toftof
analysi
shown
fig
part
complex
type
nglycan
shown
symbol
complet
estim
composit
nglycan
observ
ms
analys
shown
tabl
structur
detect
nglycan
similar
rgp
zgp
complextyp
nglycan
fig
calcul
analyz
ms
peak
area
detect
nglycan
tabl
defin
sum
base
result
ms
analys
focus
complextyp
nglycan
gp
comparison
extens
pattern
complextyp
nglycan
rgp
zgp
reveal
extend
complextyp
nglycan
rgp
zgp
fig
time
amount
nonextend
complextyp
nglycan
agalactotyp
glycan
rgp
decreas
fig
comparison
defin
glycan
tabl
nonextend
complextyp
nglycan
ie
agalactotyp
nglycan
nglycan
nacetylglucosamin
glcnac
residu
nonreduc
termin
difin
galactosyl
sialyl
nglycan
glycan
tabl
case
biantennari
nglycan
extend
complextyp
nglycan
ie
extendedtyp
nglycan
nglycan
maturatedelong
structur
known
becom
bulki
steric
hindranc
around
oglycan
like
increas
therefor
hypothes
steric
hindranc
extend
nglycan
rgp
inhibit
interact
gp
ntermin
amino
acid
residu
gp
regul
extens
nglycan
bear
rgp
treat
neuraminidas
effect
nglycan
trim
interact
gp
examin
treat
sampl
separ
sdspage
bind
mab
maackia
amurensi
leucoagglutinin
mal
ricinu
communi
recombin
examin
shown
fig
bind
mab
reveal
electrophoret
migrat
distanc
alter
bind
mal
complet
diminish
treatment
rgpbear
vlp
glycosidas
confirm
success
remov
sialic
acid
galactos
residu
bind
rgp
increas
enzymat
treatment
fig
b
result
strongli
suggest
extens
nglycan
rgp
respons
reduc
interact
mgl
lower
infect
vsv
pseudotyp
rgp
compar
vsv
pseudotyp
zgp
confirm
differenti
extent
nglycan
rgp
zgp
regul
ntermin
amino
acid
residu
gp
analyz
glycan
extens
pattern
chimer
gp
shown
fig
rel
ratio
extend
nglycan
increas
swap
ntermin
residu
zgp
rgp
contrast
swap
ntermin
residu
rgp
zgp
result
reduct
rel
ratio
extendedtyp
nglycan
result
strongli
suggest
short
peptid
sequenc
near
nterminu
gp
regul
extens
nglycan
glycanlectin
interact
play
crucial
role
virushost
interact
yet
mani
underli
mechan
welldefin
present
studi
focus
interact
glycan
present
ebov
gp
ctype
lectin
host
cell
aim
answer
question
rebov
less
pathogen
zebov
demonstr
vsv
pseudotyp
ebov
gp
infect
dc
mediat
ntermin
amino
acid
sequenc
gp
determin
differenti
infect
vsv
pseudotyp
rgp
zgp
differenti
infect
seem
depend
extens
pattern
nglycan
gp
turn
regul
ntermin
amino
acid
sequenc
gp
host
cell
molecul
includ
folat
famili
molecul
tcell
immunoglobulin
mucin
domain
ctype
lectin
express
initi
target
cell
filoviru
eg
monocyt
macrophag
dc
hepatocyt
sinusoid
endotheli
cell
report
involv
initi
infect
ctype
lectin
previous
report
divers
carbohydr
specif
instanc
dcsign
preferenti
bind
mannos
man
like
ctype
lectin
variou
carbohydr
specif
act
concert
facilit
attach
entri
ebov
dc
seem
play
predomin
role
among
lectin
nonlectin
receptor
block
monoclon
antibodi
block
infect
pseudotyp
virus
human
immatur
dc
fig
filoviru
envelop
gp
surfac
molecul
present
viral
particl
known
involv
viru
entri
cell
manicassami
cowork
report
ntermin
amino
acid
residu
import
mainten
protein
integr
format
pseudotyp
viru
viral
entri
cell
base
singl
amino
acid
mutagenesi
analysi
also
claim
sever
key
aminoacid
residu
crucial
protein
fold
howev
import
glycosyl
explor
studi
marzi
cowork
report
signal
sequenc
gp
ntermin
amino
acid
residu
affect
gp
glycosyl
result
enhanc
dcsignrmedi
viral
infect
show
highmannos
type
glycosyl
sgp
increas
signal
peptid
sgp
replac
zgp
though
studi
glycan
structur
attach
gp
structur
analys
ms
reveal
nglycan
rgp
extend
zgp
even
though
gp
prepar
cell
line
fig
extens
pattern
appar
affect
interact
bind
rgp
increas
level
zgp
remov
nglycan
fig
e
bind
rgp
also
increas
extend
glycan
trim
use
glycosidas
fig
result
support
structur
nglycan
gp
affect
interact
gp
extend
nglycan
rgp
seem
lower
bind
preferenti
bind
oglycan
decreas
capac
gp
mediat
infect
dc
macrophag
nglycan
zgp
seem
capac
fig
e
use
molecular
genet
approach
demonstr
limit
number
amino
acid
residu
gp
critic
differenti
lectin
bind
rgp
zgp
far
examin
stretch
amino
acid
residu
near
amino
terminu
gp
seem
play
key
role
also
show
stretch
amino
acid
residu
play
import
role
regul
differenti
nglycan
extens
rgp
zgp
lectinbind
potenti
glycan
extens
pattern
zgp
rgp
revers
ntermin
amino
acid
residu
gp
swap
fig
result
strongli
suggest
oligopeptid
motif
control
nglycan
extens
extens
control
howev
remain
determin
also
worthwhil
mention
contrast
previou
report
signal
sequenc
amino
acid
residu
gp
seem
involv
phenomenon
observ
effect
signal
sequenc
differenti
infect
pseudotyp
virus
bind
rebov
zebov
gp
fig
zgp
vs
vs
regard
potenti
mechan
control
nglycan
extens
assum
intracellular
local
traffick
speed
traffick
pathway
gp
might
influenc
peptid
motif
howev
far
examin
biosynthet
rate
intracellular
local
gp
seem
affect
pulsechas
experi
smethionin
incorpor
reveal
almost
ident
biosynthet
rate
rgp
zgp
fig
intracellular
local
rgp
zgp
similar
fig
attempt
prepar
vsv
pseutotyp
rgpzgp
lack
amino
acid
residu
vlp
bear
confirm
import
oligopeptid
motif
express
gp
vsv
pseudotyp
virus
vlp
confirm
immunoblot
use
mab
fig
b
howev
infecti
virus
obtain
fig
unknown
reason
band
pattern
vlp
differ
gp
fig
suggest
amino
acid
residu
gp
affect
process
gp
studi
need
elucid
mechan
peptid
sequenc
regul
nglycan
extens
collar
cowork
recent
report
result
structur
analys
nand
oglycan
recombin
ebov
gp
conclud
compar
zair
ebolaviru
sudan
ebolaviru
bundibugyo
ebolaviru
tai
forest
figur
bind
rgp
increas
glycosidas
treatment
lysat
vlp
rgp
zgp
treat
untreat
sialidas
galactosidas
electrophoret
separ
subject
immunoblot
mab
mal
remov
sialic
acid
neuac
galactos
enzymat
treatment
confirm
mal
respect
shown
crop
imag
repres
result
n
whole
blot
imag
shown
fig
b
bind
capac
glysosidasetr
rgpzgp
compar
untreat
rgpzgp
rel
intens
bind
mab
shown
n
quantif
rel
intens
untreat
zgp
set
statist
analysi
student
ttest
perform
p
ns
signific
scientif
report
ebolaviru
nglycan
composit
similar
oglycan
structur
vari
howev
contrast
studi
analyz
recombin
gp
lysat
cell
express
gp
studi
gp
vlp
close
repres
viral
particl
furthermor
analyz
rgp
repres
molecular
characterist
poorli
infecti
variant
result
nglycan
structur
howev
consist
result
nglycan
fucosyl
asialotyp
glycan
fig
accord
result
zgp
sgp
contain
lower
amount
oglycan
sialic
acid
gp
bundibugyoivori
coast
studi
necessari
prove
disprov
hypothesi
decreas
sialyl
contribut
elev
interact
gp
previou
report
show
gp
use
therapeut
target
ebov
infect
gpspecif
neutral
antibodi
protect
experiment
anim
lethal
ebov
infect
antibodi
abl
protect
mice
complet
guinea
pig
partial
anoth
neutral
antibodi
effect
guinea
pig
nonhuman
primat
recent
sever
neutral
antibodi
protect
macaqu
lethal
ebov
infect
also
report
shown
present
report
enhanc
nglycan
extens
cell
infect
ebov
infect
viru
produc
cell
may
reduc
furthermor
structur
analysi
gp
extend
nglycan
might
assist
identifi
epitop
could
use
target
effect
therapeut
antibodi
ebov
blockad
infect
also
achiev
interf
interact
gp
present
studi
also
contribut
understand
novel
regulatori
mechan
glycosyl
cell
infect
construct
chimer
gp
standard
molecular
biolog
techniqu
use
construct
chimer
gp
contain
pcagg
vector
sequenc
zgp
rgp
obtain
vector
pbluescriptrgp
vetor
respect
primer
describ
supplementari
tabl
use
gener
recombin
pseudotyp
viru
pseudotyp
virus
gener
describ
previous
modif
genom
code
region
vsv
g
protein
gene
replac
code
region
modifi
version
gfp
gene
gp
zebov
strain
mayinga
rebov
strain
pennsylvania
sebov
strain
bonifac
chimer
gp
clone
pcagg
vector
plasmid
transfect
human
embryon
kidney
cell
use
transit
takara
twentyfour
hour
transfect
cell
infect
vsvg
vsv
pseudotyp
vsvg
multipl
infect
moi
hour
cell
wash
twice
dulbecco
modifi
eagl
mediumhigh
glucos
dmemhg
without
fetal
calf
serum
fc
dmemhg
fc
medium
ad
hour
incub
co
atmospher
cultur
fluid
collect
centrifug
remov
cell
viru
stock
store
use
regard
biosafeti
level
bsl
pseudotyp
viru
categor
vlp
produc
report
previous
modif
briefli
cell
seed
cm
cultur
dish
one
day
transfect
cell
transfect
pcaggsgp
use
transit
dna
transfect
reagent
transit
plasmid
mix
ml
optimem
gibco
ad
cell
mixtur
incub
hour
cultur
medium
harvest
hour
later
centrifug
rpm
min
remov
cellular
debri
supernat
layer
sucros
cushion
ultracentrifug
rpm
hour
use
himac
cp
mx
hitachi
supernat
discard
pellet
resuspend
pb
suspens
regard
vlp
store
use
protein
amount
vlp
solut
measur
bca
protein
assay
kit
pierc
cell
cultur
cell
human
chronic
myelogen
leukemia
cell
grown
dmemhg
rpmi
medium
respect
supplement
fc
peripher
blood
mononuclear
cell
pbmc
isol
venou
blood
drawn
healthi
volunt
tokyo
metropolitan
red
cross
blood
center
tokyo
japan
centrifug
percol
densiti
gradient
monocyt
purifi
pbmc
incub
mabcoat
microbead
separ
magnet
cell
separ
system
mac
miltenyi
biotec
bergisch
gladbach
germani
column
type
ls
immatur
dc
prepar
cultur
monocyt
day
rpmi
contain
fc
uml
gmcsf
kyowakirin
ngml
gt
examin
puriti
immatur
dc
flow
cytometr
analysi
fluorescein
isothiocyan
fitc
label
antihuman
biosourc
dako
cytom
ebiosci
hladr
bd
bioscienc
pharmingen
perform
express
solubl
recombin
plasmid
encod
put
extracellular
domain
prepar
describ
previous
e
coli
express
protein
recov
first
wash
tb
contain
sigma
mm
edta
wash
h
wash
pellet
solubil
nh
oh
solubl
recombin
refold
mixtur
mm
reduc
glutathion
mm
oxid
glutathion
refold
protein
dialyz
mm
mop
buffer
ph
contain
mm
cacl
nacl
nan
solubl
rmgl
purifi
affin
chromatographi
galactosesepharos
column
use
monoclon
antibodi
mab
clone
transfect
perform
limit
dilut
method
flow
cytometr
analysi
mab
ascit
fluid
fitclabel
antimous
immunoglobulin
g
zyme
perform
determin
level
mgl
express
obtain
cell
clone
titrat
pseudotyp
viru
vero
cell
cellswel
seed
plate
one
day
infect
serial
dilut
viral
solut
made
treatment
antivsvg
antibodi
room
temperatur
min
neutral
vsv
pseudotyp
vsvg
viral
solut
dilut
viral
solut
ad
seed
cell
cell
incub
h
number
infect
cell
analyz
flow
cytometori
infect
experi
viru
titer
defin
sdspage
immunoblot
analysi
vsv
pseudotyp
gp
vlp
bear
gp
solubil
viral
gp
separ
sdspage
blot
onto
pvdf
membran
membran
block
bsa
pb
overnight
incub
antiebov
mab
dilut
follow
hrp
goat
antimous
igg
h
l
zyme
confirm
equal
load
biotinyl
lectin
tb
contain
ca
react
hour
room
temperatur
zymax
tm
streptavidin
alkalin
phosphatas
conjug
zyme
dilut
use
second
reagent
hour
room
temperatur
wash
membran
develop
use
ecl
tm
western
blot
detect
reagent
amersham
hrp
alkalin
phosphatas
substrat
kit
iv
vector
alkalin
phosphatas
band
intens
bind
antiebov
mab
bind
gp
quantifi
imag
j
imagequ
tl
ge
healthcar
softwar
measur
bind
gp
amount
gp
normal
state
first
load
amount
viral
lysat
vlp
normal
total
protein
amount
measur
use
bca
protein
assay
western
blot
analysi
perform
use
mab
band
intens
gp
quantifi
imagej
imagequ
tl
softwar
load
volum
viral
lysat
vlp
renorm
load
estim
equal
amount
gp
pngase
f
treatment
one
vlp
bear
zgp
rgp
treat
unit
pngase
f
roch
reaction
mixtur
contain
mm
edta
ph
mm
trishcl
buffer
ph
hour
viral
gp
vlp
electrophoret
separ
blot
onto
pvdf
membran
analyz
immunoblot
structur
estim
nglycan
immunoprecipit
gp
solubil
vlp
gp
separ
sdspage
gel
gel
fix
stain
cbb
biorad
stain
portion
gp
gel
excis
subject
ingel
tryptic
digest
digest
carri
h
msgrade
trypsin
wako
peptid
extract
gel
tfa
contain
acetonitril
acn
peptid
dri
speed
vac
dissolv
h
dissolv
peptid
sampl
treat
pngase
f
roch
releas
nglycan
releas
nglycan
purifi
label
use
glycoblot
method
sumitomo
bakelit
glycoblot
perform
accord
previous
describ
procedur
label
nglycan
analyz
malditof
ms
toftof
method
use
ultraflex
ii
bruker
glycosidas
treatment
vlp
bear
zgp
rgp
treat
mu
neuraminidas
clostridium
perfringen
sigma
hour
mu
streptococcu
seikagaku
co
mncl
final
concentr
mm
ad
incub
hour
glycosidasetr
vlp
subject
immunoblot
confirm
remov
neuac
gal
well
chang
mgl
bind
enzym
treatment
statist
analysi
student
pair
ttest
use
determin
statist
signific
differ
pvalu
less
consid
statist
signific
